drugset / Trial / NCT03629483

Dexmedetomidine Combined With Ropivacaine for Postoperative Continuous Femoral Nerve Block

NCT03629483 ↗

RandomizedParallel-groupQuadruple-blindPrevention

Summary

Delirium is common in the elderly after orthopedic surgery and is associated with worse outcomes. Continuous femoral nerve block is frequently used for postoperative analgesia after total knee arthoplasty. The investigators hypothesize that dexmedetomidine, when combined with ropivacaine for continuous femoral nerve block, can reduce the incidence of delirium and improve the long-term outcome in elderly patients after total knee arthroplasty.

Timeline

Start
2018-12-10
Primary completion
2018-12-14
Completion
2018-12-14

Outcome

Outcome not reported

Stopped: “The trial stopped by the sponsor because similar studies have been conducted.”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.075 ug/kg Other